1. Home
  2. SQNS vs ELUT Comparison

SQNS vs ELUT Comparison

Compare SQNS & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sequans Communications S.A.

SQNS

Sequans Communications S.A.

HOLD

Current Price

$3.06

Market Cap

48.0M

Sector

Technology

ML Signal

HOLD

ELUT

Elutia Inc.

N/A

Current Price

$0.96

Market Cap

48.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SQNS
ELUT
Founded
2003
2015
Country
France
United States
Employees
N/A
N/A
Industry
Semiconductors
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
48.0M
48.3M
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
SQNS
ELUT
Price
$3.06
$0.96
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$20.33
$6.00
AVG Volume (30 Days)
273.3K
103.1K
Earning Date
05-05-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
146.77
EPS
N/A
N/A
Revenue
N/A
$12,293,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$49.79
$10.83
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.73
$0.50
52 Week High
$10.93
$2.60

Technical Indicators

Market Signals
Indicator
SQNS
ELUT
Relative Strength Index (RSI) 38.68 42.56
Support Level $2.98 $0.86
Resistance Level $3.27 $0.99
Average True Range (ATR) 0.34 0.09
MACD -0.15 -0.01
Stochastic Oscillator 2.05 13.97

Price Performance

Historical Comparison
SQNS
ELUT

About SQNS Sequans Communications S.A.

Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its offer 5G/4G chips and modules fully optimized for non-smartphone devices. The company covers applications such as smart mobility and logistics, smart utility meters, smart cities, smart industries, e-health and wellness, and smart homes to name few. The Company has one operating segment, which is the design and marketing of semiconductor components for cellular wireless systems. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.

About ELUT Elutia Inc.

Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.

Share on Social Networks: